在ibrutinib治疗期间,皮质类固醇剂量的时间变化发生在cGVHD和肺部参与症患者中
Masako Toyosaki1, Shinichiro Machida1, Daisuke Tomizawa2
1Department of Hematology and Oncology, Tokai University Hospital, Isehara, Japan.
易布鲁替尼可能有助于减少日本患者的皮质类固醇剂量,这些患者患有慢性移植对宿主疾病 (cGVHD) 和肺部参与. 在GVH3001研究中,这种治疗没有恶化肺功能或增加症状负担.
科学领域:
- 血液学 血液学 血液学
- 免疫学 免疫学 免疫学
- 肺部病理学 肺部病理学
背景情况:
- 慢性移植对宿主疾病 (cGVHD) 可以影响肺功能.
- 皮质类固醇是一种标准的治疗方法,但有副作用.
- 易布鲁替尼是治疗类固醇依赖或耐火性cGVHD的选择.
研究的目的:
- 评估ibrutinib对日本cGVHD患者的皮质类固醇剂量,肺功能和症状的影响.
- 分析每日皮质类固醇剂量和有效性结果的时间变化.
- 通过李cGVHD症状量表来评估使用%FEV1和症状负担的肺功能.
主要方法:
- 对GVH3001研究进行了后期分析.
- 包括日本患者在基线时患有cGVHD和肺部参与.
- 监测每日皮质类固醇剂量,FEV1%和李cGVHD症状量表肺部分量表得分.
主要成果:
- 在19名患者中,有7名患者在基线时患有肺部感染.
- 五名患者的每日皮质类固醇剂量有所下降.
- %FEV1在两个患者中保持稳定,在一个患者中改善 (>80%).
- 李cGVHD 症状量表得分稳定. 李cGVHD 症状量表得分稳定.
结论:
- 易布鲁替尼可能使肺部受影响的cGVHD患者的皮质类固醇剂量减少.
- 治疗似乎没有恶化肺功能或症状负担.
- 易布鲁丁尼布为这种特定的患者亚组提供了潜在的治疗选择.
更多相关视频
10:31Surgical Angiogenesis in Porcine Tibial Allotransplantation: A New Large Animal Bone Vascularized Composite Allotransplantation Model
Published on: August 13, 2017
08:43Adoptive Immunotherapy of iNKT Cells in Glucose-6-Phosphate Isomerase G6PI-Induced RA Mice
Published on: January 31, 2020
相关概念视频
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
COPD: Management Using Bronchodilators and Corticosteroids
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
